Autologous bone marrow transplantation for acute promyelocytic leukemia in second remission: Prognostic relevance of pretransplant minimal residual disease assessment by reverse-transcription polymerase chain reaction of the PML/RARα fusion gene

Blood

Volumn 90, Issue 3, 1997, Pages 1321-1325

  Meloni, Giovanna ^a   Diverio, Daniela ^a   Vignetti, Marco ^a   Avvisati, Giuseppe ^a   Capria, Saveria ^a   Petti, Maria Concerta ^a   Mandelli, Franco ^a   Lo Coco, Francesco ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMSACRINE; CARMUSTINE; CYTARABINE; ETOPOSIDE; MITOXANTRONE; RETINOIC ACID;

ACUTE MYELOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; CANCER CHEMOTHERAPY; CANCER RECURRENCE; CANCER REGRESSION; CANCER SURVIVAL; CLINICAL ARTICLE; FEMALE; HUMAN; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCHOOL CHILD; SECOND CANCER;

EID: 0030741745     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v90.3.1321     Document Type: Article

References (23)

1. Warrell RP Jr, de Thé H, Wang Z-Y, Degos L: Acute promyelocytic leukemia. N Engl J Med 329:177, 1993
2. Grignani F, Fagioli M, Alcalay M, Longo L, Pandolfi PP, Dotti E, Blondi A, Lo Coco F, Grignani F, Pelicci PG: Acute promyelocytic leukemia: From genetics to treatment. Blood 83:10, 1994
3. Miller WH Jr, Kakizuka A, Frankel SR, Warrell RP Jr, De Blasio A, Levine K, Evans RM, Dmitrovsky E: Reverse transcription polymerase chain reaction for the rearranged retinoic acid receptor a clarifies diagnosis and detects minimal residual disease in acute promyelocytic leukemia. Proc Natl Acad Sci USA 89:2694, 1992
4. Lo Coco F, Diverio D, Pandolfi PP, Biondi A, Rossi V, Avvisati G, Ramhaldi A, Arcese W, Petti MC, Meloni G, Mandelli F, Grignani F, Masera G, Barhui T, Pelicci PG: Molecular evaluation of residual disease as a predictor of relapse in acute promyelocytic leukemia. Lancet 340:1437, 1992
5. Chang KS, Lu J, Wang G, Trujillo JM, Estey E, Cork A, Chu DT, Freireich EJ, Stass SA: The t(15;17) breakpoint in acute promyelocytic leukemia cluster within two different sites of the myl gene. Targets for the detection of minimal residual disease by polymerase chain reaction. Blood 79:54, 1992
6. Huang W, Sun G-L, Li X-S, Cao Q, Lu Y, Jang G-S, Zhang F-Q, Chai J-R, Wang Z-Y, Waxman S, Chen Z, Chen S-J: Acute promyelocytic leukemia: Relevance of two major PML-RARα isoforms and detection of minimal residual disease by retrotran-scriptase-polymerase chain reaction. Blood 82:1264, 1993
7. Fenaux P, Le Deley MC, Castaigne S, Archimbaud E, Chomienne C, Link H, Guerci A, Duarte M, Daniel MT, Bowen D, Huebner G, Bauters F, Fegueux N, Fey M, Sanz MA, Lowenberg B, Maloisel F, Auzanneau G, Sadoun A, Gardin C, Bastion Y, Gansr A, Jacky E, Dombret H, Chastang C, Degos L, for the European APL 91 Group: Effect of all-trans retinoic acid in newly diagnosed acute rpomyelocytic leukemia. Blood 82:341, 1993
8. Frankel SR, Eardley A, Heller G, Berman E, Miller WH Jr, Dmitrovsky E, Warrell RP Jr: All-trans retinoic acid for acute promyelocytic leukemia. Results of the New York study. Ann Intern Med 120:1722, 1995
9. Kanamuru A, Takemoto Y, Tanimoto M, Murakami H, Asou N, Kobayashi T, Kuriyama K, Ohmoto E, Sakamaki H, Tsubaki K, Hiraoka A, Yamada O, Oh H, Saito K, Matsuda S, Minato K, Ohno R, and the Japan Adult Leukemia Study Group: All-trans retinoic acid for the treatment of newly diagnosed acute promyelocytic leukemia. Blood 85:1202, 1995
10. Tallman MS, Andersen J, Schiffer CA, Appelbaum FR, Feusner JE, Woods WG, Ogden A, Weinstein H, Shepherd L, Rowe JM. Wiernik PH: Phase III Randomized study of All-trans retinoic acid (ATRA) vs daunorubicin (D) and cytosine arabinoside (A) as induction therapy and ATRA vs observation as maintenance therapy for patients with previously untreated acute promyelocytic leukemia (APL). Blood 86:125a, 1995 (abstr, suppl 1)
11. Lo Coco F, Diverio D, Avvisati G, Luciano A, Biondi A, Mandelli F: High frequency of early molecular remission in acute promyelocytic leukemia by combined all-trans retinoic acid and idarubicin. Blood 86:265a, 1995 (abstr, suppl 1)
12. Avvisati G, Lo Coco F, Diverio D, Falda M, Ferrara F, Lazzarino M, Russo D, Petti MC, Mandelli F: AIDA (all-trans retinoic acid + idarubicin) in newly diagnosed acute promyelocytic leukemia: A GIMEMA pilot study. Blood 88:1390, 1996
13. Mandelli F, Labopin M, Granena A, Iriondo A, Prentice G, Bacigalupo A, Sierra J, Meloni G, Frassoni F, Goldman J, Gratwhol A, Gorin NC, for the EBMT: European survey of bone marrow transplantation in acute promyelocytic leukemia. Bone Marrow Transplant 14:293, 1994
14. Meloni G, De Fabritiis P, Petti MC, Mandelli F: BAVC regimen and autologous bone marrow transplantation in patients with acute myelogenous leukemia in second remission. Blood 75:2282, 1990
15. Meloni G, Vignetti M, Avvisati G, Capria S, Micozzi A, Giona F, Mandelli F: BAVC regimen and autograft for acute myelogenous leukemia in second complete remission. Bone Marrow Transplant 18:693, 1996
16. Miller WH Jr, Levine K, De Blasio A, Frankel SR, Dmitrovsky E, Warrell RP Jr: Detection of minimal residual disease in acute promyelocytic leukemia by a reverse transcription polymerase chain reaction. Blood 82:1689, 1993
17. Fukutani H, Naoe T, Ohno R, Yoshida H, Kiyoi H, Miyawaki S, Morishita H, Sano F, Kamibayashi H, Matsue K, Miyake T, Hasegawa S, Ueda Y, Kato Y, Kobayashi H, Shimazaki C, Kobayashi M, Kurane R, Sakota H, Masaki K, Wakayama T, Tohyama K, Nonaka Y, Natori H: Prognostic significance of the RT-PCR assay of PML/RARα transcripts in acute promyelocytic leukemia. Leukemia 9:588, 1995
18. Diverio D, Pandolfi PP, Biondi A, Avvisati G, Petti MC, Mandelli F, Pelicci PG, Lo Coco F: Absence of RT-PCR detectable residual disease in acute promyelocytic leukemia in long term remission. Blood 85:3556, 1993
19. Perego RA, Marenco P, Bianchi C, Cairoli R, Urnbano M, Nosari AM, Muti G, Morra E, Del Monte U: PML/RARα transcripts monitored by polymerase chain reaction in acute promyelocytic leukemia during complete remission, relapse and after bone marrow transplantation. Leukemia 10:207, 1996
20. Avvisati G, Petti MC, Liso V, Lazzarino M, Leone G, Resegotti L, Fioritoni G, Mandelli F: All-trans retinoic acid (ATRA) in the treatment of acute promyelocytic leukemia (APL): Experience of the Italian Cooperative Group GIMEMA. Blood 82:250a, 1993 (abstr, suppl 1)
21. Meloni G, De Fabritiis P, Papa G, Amadori S, Pulsoni A, Simone F, Mandelli F: Cryopreserved autologous bone marrow infusion following high dose chemotherapy in patients with acute myeloblastic leukemia in first relapse. Leuk Res 9:407, 1985
22. Tutschka PJ, Copelan EA, Klein JP: Bone marrow transplantation for leukemia following a new busulfan and cyclophosphamide regimen. Blood 70:1382, 1987
23. Chomczynsky P, Sacchi N: Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-choroform extraction. Anal Biochem 162:156, 1987